In vitro models of the crosstalk between multiple myeloma and stromal cells recapitulate the mild NF-κB activation observed in vivo

Multiple myeloma (MM) is linked to chronic NF-kappa B activity in myeloma cells, but this activity is generally considered a cell-autonomous property of the cancer cells. The precise extent of NF-kappa B activation and the contributions of the physical microenvironment and of cell-to-cell communications remain largely unknown. By quantitative immunofluorescence, we found that NF-kappa B is mildly and heterogeneously activated in a fraction of MM cells in human BMs, while only a minority of MM cells shows a strong activation. To gain quantitative insights on NF-kappa B activation in living MM cells, we combined advanced live imaging of endogenous p65 Venus-knocked-in in MM.1S and HS-5 cell lines to model MM and mesenchymal stromal cells (MSCs), cell co-cultures, microfluidics and custom microbioreactors to mimic the 3D-interactions within the bone marrow (BM) microenvironment. We found that i) reciprocal MM-MSC paracrine crosstalk and cell-to-scaffold interactions shape the inflammatory response in the BM; ii) the pro-inflammatory cytokine IL-1 beta, abundant in MM patients' plasma, activates MSCs, whose paracrine signals are responsible for strong NF-kappa B activation in a minority of MM cells; iii) IL-1 beta, but not TNF-alpha, activates NF-kappa B in vivo in BM-engrafted MM cells, while its receptor inhibitor Anakinra reduces the global NF-kappa B activation. We propose that NF-kappa B activation in the BM of MM patients is mild, restricted to a minority of cells and modulated by the interplay of restraining physical microenvironmental cues and activating IL-1 beta-dependent stroma-to-MM crosstalk.